← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
AntibodystaleRochePhase 2

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyRochePhase 2

Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib (Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib)

Platinum-sensitive Relapsed Ovarian Cancer · Platinum-sensitive Relapsed Ovarian Canc

#Platinum-sensitiveRelapsedOvaria#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodyBiologicstaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleMedical College of WisconsinPhase 1

atezolizumab (Tecentriq, Adjuvant Atezolizumab)

Head and Neck Neoplasm · Head and Neck Neoplasm

#HeadandNeckNeoplasm#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyUniversity of Kansas Medical Ce…Phase 2

pembrolizumab (Keytruda, Adjuvant Treatment - mFOLFOX & Pembrolizumab)

Gastro Esophageal Junction Cancer; Stomach Cancer · Gastro Esophageal Junction Cancer

#GastroEsophagealJunctionCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 3

nivolumab (Opdivo, Adjuvant nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Ado-trastuzumab emtamsine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleCytoMed Therapeutics Pte LtdPhase 1

Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell (Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell)

Colorectal Cancer; Triple Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleErasmus Medical CenterPhase 2

Adoptive therapy with autologous MC2 TCR T cells (Adoptive therapy with autologous MC2 TCR T cells)

Melanoma; Melanoma, Uveal · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRegeneronPreclinical

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

AMD · AMD

#AMD#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyChinese Medical AssociationApproved

Akkermansia muciniphila + Infliximab (Akkermansia muciniphila + Infliximab)

Crohn's Diseases · Crohn's Diseases

#CrohnsDiseases#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicRemeGen Co., Ltd.Govitecan in Untreated, Adv…Phase 2

Albumin-bound Paclitaxone (Albumin-bound Paclitaxone)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleLei LiPhase 2

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

Ovarian Carcinoma; Platinum-resistant Ovarian Cancer · Ovarian Carcinoma

#OvarianCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleChina Medical University Hospit…Phase 1

nivolumab (Opdivo, Alecensa, Alectinib, Alectinib (Alecensa), Nivolumab (Opdivo))

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase1#항체#면역항체+2
효능 ORR 73.3%임상시험 1상태 ACTIVE
CGTBiologicstaleMayo ClinicPhase 1

Alefacept (Alefacept)

Lymphoma · Lymphoma

#Lymphoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleGoethe UniversityPhase 2

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

Adult Acute Lymphocytic Leukemia T-cell; Lymphoma, Lymphoblastic · Adult Acute Lymphocytic Leukemia T-cell

#AdultAcuteLymphocyticLeukemiaT-c#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleGerman CLL Study GroupPhase 2

Alemtuzumab i.v. (Alemtuzumab i.v.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

82 / 209 페이지

← 이전다음 →